![HL Machine](https://iperfusion.org/wp-content/uploads/2023/12/shutterstock_1048547738-scaled-e1702903922706-300x169.webp)
Comparison of 6% Hydroxyethyl Starch 130/0.4 and Ringer’s Lactate as Priming Solutions in Patients Undergoing Isolated Open Heart Valve Surgery: A Double-Blind Randomized Controlled Trial
This study compared the outcomes of heart valve surgery patients undergoing cardiopulmonary bypass with two different priming solutions: 6% hydroxyethyl starch (HES) 130/0.4 and ringer’s lactate (RL). The results indicate that using HES in addition to RL for priming increased the risk of blood product transfusion during hospitalization compared to using RL alone in this patient population.